Hematologic Diseases, Leukemia, Lymphoma
Conditions
Brief summary
The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.
Detailed description
The purpose of this study is to acquire critical tissue and biological samples that can be evaluated to elucidate underlying mechanisms of disease control, transplant related complications and overall outcomes
Interventions
PROCEDUREcollection and storage of tissue samples for research
Tissue samples include blood draws for the donor and recipient. A bone marrow sample may be obtained from the recipient. If the recipient undergoes a tissue biopsy for clinical reasons, a small fraction may be removed for research purposes. A small fraction of the donor graft may be removed at the time of collection for research.
Sponsors
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Stanford University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
- All hematopoietic cell transplant recipients and donors who agree to participate
Exclusion criteria
- Subject does not agree to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identify and characterize proteins and genes that may contribute to the development and progression of cancer. | blood sample is collected prior transplant, periodically during the first three months and then indefinately at follow up |
Countries
United States
Outcome results
None listed